Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
AT1 receptor antagonists are a group of pharmaceuticals that modulate the renin–angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure), diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure. They block the activation of AT1receptors, preventing the binding of angiotensin II.
The report details the trend, potential and market size of AT1 Receptor Antagonists market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of AT1 Receptor Antagonistsmarket, defines the market attractiveness level of AT1 Receptor Antagonists market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of AT1 Receptor Antagonists industry, describes the types of AT1 Receptor Antagonists market, the applications of major players and the market size, and deeply analyzes the current situation of the global AT1 Receptor Antagonists market and the development prospects and opportunities of AT1 Receptor Antagonists industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global AT1 Receptor Antagonists market in Chapter 13.
By Player:
Teva Pharmaceutical
Merck
Bayer
Sanofi SA
Bristol-Myers Squibb
Eli Lilly and Company
Jhonson and Johnson
Astra Zeneca
GSK
Pfizer
Novartis
By Type:
Valsartan
Telmisartan
Losartan
Irbesartan
Azilsartan
Olmesartan
By End-User:
Hypertension
Cardiovascular Diseases
Kidney Diseases
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 AT1 Receptor Antagonists Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 AT1 Receptor Antagonists Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 AT1 Receptor Antagonists Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 AT1 Receptor Antagonists Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise AT1 Receptor Antagonists Market Analysis and Outlook to 2022
-
7.1 Global AT1 Receptor Antagonists Consumption (2017-2022)
-
7.2 United States AT1 Receptor Antagonists Consumption (2017-2022)
-
7.3 Europe AT1 Receptor Antagonists Consumption (2017-2022)
-
7.4 China AT1 Receptor Antagonists Consumption (2017-2022)
-
7.5 Japan AT1 Receptor Antagonists Consumption (2017-2022)
-
7.6 India AT1 Receptor Antagonists Consumption (2017-2022)
-
7.7 South Korea AT1 Receptor Antagonists Consumption (2017-2022)
8 Region and Country-wise AT1 Receptor Antagonists Market Analysis and Outlook to 2028
-
8.1 Global AT1 Receptor Antagonists Consumption Forecast (2022-2028)
-
8.2 United States AT1 Receptor Antagonists Consumption Forecast (2022-2028)
-
8.3 Europe AT1 Receptor Antagonists Consumption Forecast (2022-2028)
-
8.4 China AT1 Receptor Antagonists Consumption Forecast (2022-2028)
-
8.5 Japan AT1 Receptor Antagonists Consumption Forecast (2022-2028)
-
8.6 India AT1 Receptor Antagonists Consumption Forecast (2022-2028)
-
8.7 South Korea AT1 Receptor Antagonists Consumption Forecast (2022-2028)
9 Global AT1 Receptor Antagonists Market Outlook by Types and Applications to 2022
-
9.1 Global AT1 Receptor Antagonists Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Valsartan Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Telmisartan Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Losartan Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Irbesartan Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Azilsartan Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Olmesartan Consumption and Growth Rate (2017-2022)
-
9.2 Global AT1 Receptor Antagonists Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hypertension Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Kidney Diseases Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global AT1 Receptor Antagonists Market Outlook by Types and Applications to 2028
-
10.1 Global AT1 Receptor Antagonists Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Valsartan Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Telmisartan Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Losartan Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Irbesartan Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Azilsartan Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Olmesartan Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global AT1 Receptor Antagonists Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hypertension Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Kidney Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global AT1 Receptor Antagonists Import and Export Analysis (Top 5 Countries)
-
11.1 Global AT1 Receptor Antagonists Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global AT1 Receptor Antagonists Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 AT1 Receptor Antagonists Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global AT1 Receptor Antagonists Market Competitive Analysis
-
14.1 Teva Pharmaceutical
-
14.1.1 Teva Pharmaceutical Company Details
-
14.1.2 Teva Pharmaceutical AT1 Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Teva Pharmaceutical AT1 Receptor Antagonists Product and Service
-
14.2 Merck
-
14.2.1 Merck Company Details
-
14.2.2 Merck AT1 Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Merck AT1 Receptor Antagonists Product and Service
-
14.3 Bayer
-
14.3.1 Bayer Company Details
-
14.3.2 Bayer AT1 Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bayer AT1 Receptor Antagonists Product and Service
-
14.4 Sanofi SA
-
14.4.1 Sanofi SA Company Details
-
14.4.2 Sanofi SA AT1 Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Sanofi SA AT1 Receptor Antagonists Product and Service
-
14.5 Bristol-Myers Squibb
-
14.5.1 Bristol-Myers Squibb Company Details
-
14.5.2 Bristol-Myers Squibb AT1 Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bristol-Myers Squibb AT1 Receptor Antagonists Product and Service
-
14.6 Eli Lilly and Company
-
14.6.1 Eli Lilly and Company Company Details
-
14.6.2 Eli Lilly and Company AT1 Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Eli Lilly and Company AT1 Receptor Antagonists Product and Service
-
14.7 Jhonson and Johnson
-
14.7.1 Jhonson and Johnson Company Details
-
14.7.2 Jhonson and Johnson AT1 Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Jhonson and Johnson AT1 Receptor Antagonists Product and Service
-
14.8 Astra Zeneca
-
14.8.1 Astra Zeneca Company Details
-
14.8.2 Astra Zeneca AT1 Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Astra Zeneca AT1 Receptor Antagonists Product and Service
-
14.9 GSK
-
14.9.1 GSK Company Details
-
14.9.2 GSK AT1 Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 GSK AT1 Receptor Antagonists Product and Service
-
14.10 Pfizer
-
14.10.1 Pfizer Company Details
-
14.10.2 Pfizer AT1 Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Pfizer AT1 Receptor Antagonists Product and Service
-
14.11 Novartis
-
14.11.1 Novartis Company Details
-
14.11.2 Novartis AT1 Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Novartis AT1 Receptor Antagonists Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of AT1 Receptor Antagonists
-
Figure AT1 Receptor Antagonists Picture
-
Table Global AT1 Receptor Antagonists Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global AT1 Receptor Antagonists Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global AT1 Receptor Antagonists Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global AT1 Receptor Antagonists Consumption by Country (2017-2022)
-
Figure United States AT1 Receptor Antagonists Consumption and Growth Rate (2017-2022)
-
Table Europe AT1 Receptor Antagonists Consumption and Growth Rate (2017-2022)
-
Figure China AT1 Receptor Antagonists Consumption and Growth Rate (2017-2022)
-
Figure Japan AT1 Receptor Antagonists Consumption and Growth Rate (2017-2022)
-
Figure India AT1 Receptor Antagonists Consumption and Growth Rate (2017-2022)
-
Figure South Korea AT1 Receptor Antagonists Consumption and Growth Rate (2017-2022)
-
Figure Global AT1 Receptor Antagonists Consumption Forecast by Country (2022-2028)
-
Figure United States AT1 Receptor Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe AT1 Receptor Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure China AT1 Receptor Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan AT1 Receptor Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure India AT1 Receptor Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea AT1 Receptor Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Valsartan Consumption and Growth Rate (2017-2022)
-
Figure Global Telmisartan Consumption and Growth Rate (2017-2022)
-
Figure Global Losartan Consumption and Growth Rate (2017-2022)
-
Figure Global Irbesartan Consumption and Growth Rate (2017-2022)
-
Figure Global Azilsartan Consumption and Growth Rate (2017-2022)
-
Figure Global Olmesartan Consumption and Growth Rate (2017-2022)
-
Figure Global Hypertension Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Kidney Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Valsartan Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Telmisartan Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Losartan Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Irbesartan Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Azilsartan Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Olmesartan Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hypertension Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kidney Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global AT1 Receptor Antagonists Import by Region (Top 5 Countries) (2017-2028)
-
Table Global AT1 Receptor Antagonists Export by Region (Top 5 Countries) (2017-2028)
-
Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical AT1 Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical AT1 Receptor Antagonists Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck AT1 Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck AT1 Receptor Antagonists Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer AT1 Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AT1 Receptor Antagonists Product and Service
-
Table Sanofi SA (Foundation Year, Company Profile and etc.)
-
Table Sanofi SA AT1 Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi SA AT1 Receptor Antagonists Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb AT1 Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb AT1 Receptor Antagonists Product and Service
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company AT1 Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company AT1 Receptor Antagonists Product and Service
-
Table Jhonson and Johnson (Foundation Year, Company Profile and etc.)
-
Table Jhonson and Johnson AT1 Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jhonson and Johnson AT1 Receptor Antagonists Product and Service
-
Table Astra Zeneca (Foundation Year, Company Profile and etc.)
-
Table Astra Zeneca AT1 Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astra Zeneca AT1 Receptor Antagonists Product and Service
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK AT1 Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK AT1 Receptor Antagonists Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer AT1 Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer AT1 Receptor Antagonists Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis AT1 Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AT1 Receptor Antagonists Product and Service
-
